The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation

Josephine C Owen1,2, Steven P Garrick1,2, Briana M Peterson1,2

  • 1Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.

Insights

Preterm birth complications can impair infant circulatory transition. Targeting interleukin-1 (IL-1) inflammation shows promise for improving outcomes in premature infants born due to chorioamnionitis or fetal growth restriction.

Area of Science:

  • Neonatal Physiology
  • Perinatal Medicine
  • Immunology

Background:

  • Preterm birth (<37 weeks gestational age) affects millions globally, increasing risks of early life diseases.
  • Improved survival in extremely premature infants is linked to higher incidence of short- and long-term morbidities.
  • The transition from fetal to neonatal circulation is critical and can be impaired by conditions like chorioamnionitis and fetal growth restriction (FGR).

Purpose of the Study:

  • To outline mechanistic pathways of impaired circulatory transition in preterm infants.
  • To explore the role of interleukin-1 (IL-1) in chorioamnionitis and FGR-related circulatory abnormalities.
  • To investigate the therapeutic potential of targeting IL-1 for improving perinatal circulatory transition.

Main Methods:

  • Review of mechanistic pathways linking chorioamnionitis and FGR to circulatory transition abnormalities.
  • Analysis of the role of pro-inflammatory cytokines, particularly IL-1, in perinatal inflammation.
  • Exploration of preclinical findings on the efficacy of anti-inflammatory strategies targeting IL-1.

Main Results:

  • Maternal chorioamnionitis and fetal growth restriction (FGR) are common causes of preterm birth associated with impaired circulatory transition.
  • Interleukin-1 (IL-1) plays a central role in the pathogenesis of chorioamnionitis-related perinatal inflammatory diseases.
  • Inflammation, potentially mediated by IL-1, is implicated in FGR and in-utero hypoxia, affecting circulatory adaptation.

Conclusions:

  • Abnormalities in transitional circulation are linked to common preterm birth causes like chorioamnionitis and FGR.
  • Targeting IL-1-driven inflammation presents a promising therapeutic strategy for improving circulatory transition in at-risk preterm infants.
  • Early and effective anti-inflammatory interventions hold potential for mitigating short- and long-term sequelae of impaired perinatal adaptation.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.5K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.7K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K